Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sue Gail Eckhardt currently holds 25,891 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sue Gail Eckhardt has been a net neutral trader of SYRS stock. They have purchased $0 and sold $0 worth of shares.
Sue Gail Eckhardt's most recent insider trade was on May 27, 2026, when they sold 8,367 shares at $0.00 per share.
Sue Gail Eckhardt serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Sue Gail Eckhardt holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sue Gail Eckhardt has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sue Gail Eckhardt was on May 27, 2026, when they purchased $0 worth of EXEL shares. This transaction involved 8,367 shares at N/A per share.
Sue Gail Eckhardt currently owns 25,891 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sue Gail Eckhardt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sue Gail Eckhardt has 8 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Sue Gail Eckhardt and 40,000+ other insiders.